M&A Deal Summary

Eurofins Discovery Acquires Discovery Biomed

On July 5, 2022, Eurofins Discovery acquired life science company Discovery Biomed

Acquisition Highlights
  • This is Eurofins Discovery’s 1st transaction in the Life Science sector.
  • This is Eurofins Discovery’s 1st transaction in the United States.
  • This is Eurofins Discovery’s 1st transaction in Alabama.

M&A Deal Summary
Date 2022-07-05
Target Discovery Biomed
Sector Life Science
Buyer(s) Eurofins Discovery
Deal Type Add-on Acquisition

Target

Discovery Biomed

Birmingham, Alabama, United States
Discovery Biomed is an operator of boutique biotechnology company seeks to contribute to improvements in human health through its expertise, work, and facilities by providing partners and clients with pilot screening and high-throughput screening (HTS) services for therapeutic-related bioassays, providing partners and clients with custom immortalized cell lines, and performing therapeutics discovery for certain failure-to-secrete diseases in humans. Discovery Biomed was founded in 2007 and is based in Birmingham, Alabama.

Search 199,847 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Eurofins Discovery

St Charles, Missouri, United States
Category Company
Sector Life Science
DESCRIPTION

Eurofins Discovery provides drug discovery researchers with the largest and most diverse portfolio of standard and custom in vitro safety & pharmacology assays and panels for drug screening and profiling. Eurofins Discovery is based in St Charles, Missouri.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Alabama) 1 of 1
Country (United States) 1 of 1
Year (2022) 1 of 1
Mergr

Product

Company

Legal